CoChat
Sign Up
Cited by 46

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis

McCoy, Claire E.·2017·Advances in Experimental Medicine and Biology
DOI 10.1007/978-981-10-5987-2_5
Open this paper in CoChat — free account

Abstract

microRNAs play a fundamental role in the immune system. One particular microRNA, miR-155 plays a critical role in hematopoietic cell development and tightly regulates innate and adaptive immune responses in response to infection. However, its dysregulation, more specifically its overexpression, is closely associated with various inflammatory disorders. The purpose of this review is to consolidate how miR-155 underpins a variety of processes that contribute to the pathology of multiple sclerosis (MS). In particular, the impact of miR-155 is discussed with respect to human pathology and animal models. How miR-155 contributes to the activation of pathogenic immune cells, the permeability of the blood-brain barrier, and neurodegeneration in relation to MS is described. Many environmental risk factors associated with MS susceptibility can cause upregulation of miR-155, while many of the current disease-modifying treatments may work by inhibiting miR-155. From this review, it is clear that miR-155 is a realistic and feasible diagnostic, prognostic, and therapeutic target for the treatment of MS.

Overview

Integrity signals

Registry

Crossref · 10.1007/978-981-10-5987-2_5

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 126

  1. Albrecht P, Bouchachia I, Goebels N, Henke N, Hofstetter HH et al (2012) Effects of dimethyl fumarate on neuroprotection and immunomodulation. J Neuroinflammation 9:163 · DOI
  2. Ambros V (2004) The functions of animal microRNAs. Nature 431:350–355 · DOI · Paper page
  3. Balusu S, Van Wonterghem E, De Rycke R, Raemdonck K, Stremersch S et al (2016) Identification of a novel mechanism of blood-brain communication during peripheral inflammation via choroid plexus-derived extracellular vesicles. EMBO Mol Med 8:1162–1183 · DOI
  4. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297 · DOI
  5. Belbasis L, Bellou V, Evangelou E, Ioannidis JP, Tzoulaki I (2015) Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol 14:263–273 · DOI
  6. Benedek G, Meza-Romero R, Jordan K, Keenlyside L, Offner H et al (2015) HLA-DRalpha1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection. J Neuroinflammation 12:123 · DOI
  7. Bruning U, Cerone L, Neufeld Z, Fitzpatrick SF, Cheong A et al (2011) MicroRNA-155 promotes resolution of hypoxia-inducible factor 1alpha activity during prolonged hypoxia. Mol Cell Biol 31:4087–4096 · DOI
  8. Bruns H, Bottcher M, Qorraj M, Fabri M, Jitschin S et al (2017) CLL-cell-mediated MDSC induction by exosomal miR-155 transfer is disrupted by vitamin D. Leukemia 31:985–988 · DOI
  9. Cerutti C, Soblechero-Martin P, Wu D, Lopez-Ramirez MA, de Vries H et al (2016) MicroRNA-155 contributes to shear-resistant leukocyte adhesion to human brain endothelium in vitro. Fluids Barriers CNS 13:8 · DOI
  10. Chekulaeva M, Filipowicz W (2009) Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21:452–460 · DOI · Paper page
  11. Chen Y, Liu W, Sun T, Huang Y, Wang Y et al (2013) 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol 190:3687–3695 · DOI
  12. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK et al (2011) MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol 8:467–477 · DOI
  13. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S et al (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 103:7024–7029 · DOI
  14. Cox MB, Cairns MJ, Gandhi KS, Carroll AP, Moscovis S et al (2010) MicroRNAs miR-17 and miR-20a inhibit T cell activation genes and are under-expressed in MS whole blood. PLoS One 5:e12132
  15. Cross AH, Naismith RT (2014) Established and novel disease-modifying treatments in multiple sclerosis. J Int Med 275(4):350–363. doi:10.1111/joim.12203. Epub 2014 March 11. Review. PubMed PMID:24444048 · DOI
  16. Cua DJ, Groux H, Hinton DR, Stohlman SA, Coffman RL (1999) Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis. J Exp Med 189:1005–1010 · DOI
  17. Cua DJ, Hutchins B, LaFace DM, Stohlman SA, Coffman RL (2001) Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J Immunol 166:602–608 · DOI
  18. Dargahi N, Katsara M, Tselios T, Androutsou ME, de Courten M et al (2017) Multiple sclerosis: immunopathology and treatment update. Brain Sci 7 · DOI
  19. Eis PS, Tam W, Sun L, Chadburn A, Li Z et al (2005) Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102:3627–3632 · DOI
  20. Escobar TM, Kanellopoulou C, Kugler DG, Kilaru G, Nguyen CK et al (2014) miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression. Immunity 40:865–879 · DOI
  21. Faravelli I, Corti S (2017) MicroRNA-directed neuronal reprogramming as a therapeutic strategy for neurological diseases. Mol Neurobiol
  22. Freilich RW, Woodbury ME, Ikezu T (2013) Integrated expression profiles of mRNA and miRNA in polarized primary murine microglia. PLoS One 8:e79416 · DOI · Paper page
  23. Galloway DA, Moore CS (2016) miRNAs as emerging regulators of oligodendrocyte development and differentiation. Front cell. Dev Biol 4:59
  24. Gandhi R (2015) miRNA in multiple sclerosis: search for novel biomarkers. Mult Scler 21:1095–1103 · DOI
  25. Gantier MP, McCoy CE, Rusinova I, Saulep D, Wang D et al (2011) Analysis of microRNA turnover in mammalian cells following Dicer1 ablation. Nucleic Acids Res 39:5692–5703 · DOI
  26. Gao L, Ai J, Xie Z, Zhou C, Liu C et al (2015) Dynamic expression of viral and cellular microRNAs in infectious mononucleosis caused by primary Epstein-Barr virus infection in children. Virol J 12:208 · DOI
  27. Gatto G, Rossi A, Rossi D, Kroening S, Bonatti S, et al. (2008) Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB · DOI
  28. Goverman J (2009) Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 9:393–407 · DOI
  29. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, et al. (2007) Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet
  30. Guedes JR, Custodia CM, Silva RJ, de Almeida LP, Pedroso de Lima MC et al (2014) Early miR-155 upregulation contributes to neuroinflammation in Alzheimer’s disease triple transgenic mouse model. Hum Mol Genet 23:6286–6301 · DOI · Paper page
  31. Guinn D, Ruppert AS, Maddocks K, Jaglowski S, Gordon A et al (2015) miR-155 expression is associated with chemoimmunotherapy outcome and is modulated by Bruton’s tyrosine kinase inhibition with Ibrutinib. Leukemia 29:1210–1213 · DOI
  32. Hartmann FJ, Khademi M, Aram J, Ammann S, Kockum I et al (2014) Multiple sclerosis-associated IL2RA polymorphism controls GM-CSF production in human TH cells. Nat Commun 5:5056 · DOI
  33. Hecker M, Thamilarasan M, Koczan D, Schroder I, Flechtner K et al (2013) MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patients. Int J Mol Sci 14:16087–16110 · DOI
  34. Hu R, Huffaker TB, Kagele DA, Runtsch MC, Bake E et al (2013) MicroRNA-155 confers encephalogenic potential to Th17 cells by promoting effector gene expression. J Immunol 190:5972–5980 · DOI
  35. Huitinga I, van Rooijen N, de Groot CJ, Uitdehaag BM, Dijkstra CD (1990) Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med 172:1025–1033 · DOI · Paper page
  36. International Multiple Sclerosis Genetics C, Beecham AH, Patsopoulos NA, Xifara DK, Davis MF, et al (2013) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet 45:1353–1360 · DOI · Paper page
  37. Iosue I, Quaranta R, Masciarelli S, Fontemaggi G, Batassa EM et al (2013) Argonaute 2 sustains the gene expression program driving human monocytic differentiation of acute myeloid leukemia cells. Cell Death Dis 4:e926 · DOI
  38. Jablonski KA, Gaudet AD, Amici SA, Popovich PG, Guerau-de-Arellano M (2016) Control of the inflammatory macrophage transcriptional signature by miR-155. PLoS One 11:e0159724 · DOI · Paper page
  39. Jagot F, Davoust N (2016) Is it worth considering circulating microRNAs in multiple sclerosis? Front Immunol 7:129 · DOI · Paper page
  40. Jevtic B, Timotijevic G, Stanisavljevic S, Momcilovic M, Mostarica Stojkovic M et al (2015) Micro RNA-155 participates in re-activation of encephalitogenic T cells. Biomed Pharmacother 74:206–210 · DOI
  41. Jiang Z, Jiang JX, Zhang GX (2014) Macrophages: a double-edged sword in experimental autoimmune encephalomyelitis. Immunol Lett 160:17–22 · DOI
  42. Junker A, Krumbholz M, Eisele S, Mohan H, Augstein F et al (2009) MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain 132:3342–3352 · DOI · Paper page
  43. Karkeni E, Bonnet L, Marcotorchino J, Tourniaire F, Astier J, et al. (2017) Vitamin D limits inflammation-linked microRNA expression in adipocytes in vitro and in vivo: A new mechanism for the regulation of inflammation by vitamin D. Epigenetics:0 · DOI · Paper page
  44. Keller A, Leidinger P, Lange J, Borries A, Schroers H et al (2009) Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One 4:e7440 · DOI
  45. Keller A, Leidinger P, Steinmeyer F, Stähler C, Franke A, Hemmrich-Stanisak G, Kappel A, Wright I, Dörr J, Paul F, Diem R, Tocariu-Krick B, Meder B, Backes C, Meese E, Ruprecht K (2014) Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler 20(3):295–303. doi:10.1177/1352458513496343. Epub 2013 Jul 8. PubMed PMID:23836875 · DOI
  46. Keller A, Leidinger P, Steinmeyer F, Stahler C, Franke A et al (2014) Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler 20:295–303 · DOI
  47. Kin K, Miyagawa S, Fukushima S, Shirakawa Y, Torikai K et al (2012) Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm. J Am Heart Assoc 1:e000745
  48. Kluiver J, Poppema S, de Jong D, Blokzijl T, Harms G, Jacobs S, Kroesen BJ, van den Berg A (2005) BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J Pathol 207(2):243–249. PubMed PMID:16041695 · DOI
  49. Lashine YA, Salah S, Aboelenein HR, Abdelaziz AI (2015) Correcting the expression of miRNA-155 represses PP2Ac and enhances the release of IL-2 in PBMCs of juvenile SLE patients. Lupus 24(3):240–247. doi:10.1177/0961203314552117. Epub 2014 September 24. PubMed PMID:25253569 · DOI
  50. Li Z, Rana TM (2014) Therapeutic targeting of microRNAs: current status and future challenges. Nat Rev Drug Discov 13:622–638 · DOI
  51. Linnstaedt SD, Gottwein E, Skalsky RL, Luftig MA, Cullen BR (2010) Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J Virol 84:11670–11678 · DOI · Paper page
  52. Liu G, Abraham E (2013) MicroRNAs in immune response and macrophage polarization. Arterioscler Thromb Vasc Biol 33:170–177 · DOI
  53. Lopez-Ramirez MA, Wu D, Pryce G, Simpson JE, Reijerkerk A et al (2014) MicroRNA-155 negatively affects blood-brain barrier function during neuroinflammation. FASEB J 28:2551–2565 · DOI · Paper page
  54. Louafi F, Martinez-Nunez RT, Sanchez-Elsner T (2010) MicroRNA-155 targets SMAD2 and modulates the response of macrophages to transforming growth factor-{beta}. J Biol Chem 285:41328–41336 · DOI · Paper page
  55. Lu C, Huang X, Zhang X, Roensch K, Cao Q et al (2011) miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 117:4293–4303 · DOI
  56. Lu F, Weidmer A, Liu CG, Volinia S, Croce CM et al (2008) Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 82:10436–10443 · DOI · Paper page
  57. Lund C, Nakken KO, Edland A, Celius EG (2014) Multiple sclerosis and seizures: incidence and prevalence over 40 years. Acta Neurol Scand 130:368–373 · DOI
  58. Mameli G, Arru G, Caggiu E, Niegowska M, Leoni S et al (2016) Natalizumab therapy modulates miR-155, miR-26a and Proinflammatory cytokine expression in MS patients. PLoS One 11:e0157153 · DOI
  59. Mancardi G, Saccardi R (2008) Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol 7:626–636 · DOI
  60. Martinelli-Boneschi F, Fenoglio C, Brambilla P, Sorosina M, Giacalone G et al (2012) MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci Lett 508:4–8 · DOI
  61. Martinez-Nunez RT, Louafi F, Sanchez-Elsner T (2011) The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1). J Biol Chem 286:1786–1794 · DOI
  62. McCoy CE, Sheedy FJ, Qualls JE, Doyle SL, Quinn SR et al (2010) IL-10 inhibits miR-155 induction by toll-like receptors. J Biol Chem 285:20492–20498 · DOI
  63. Michell-Robinson MA, Moore CS, Healy LM, Osso LA, Zorko N et al (2016) Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis. Ann Clin Transl Neurol 3:27–41 · DOI
  64. Minagar A, Alexander JS (2003) Blood-brain barrier disruption in multiple sclerosis. Mult Scler 9:540–549 · DOI
  65. Moutsianas L, Jostins L, Beecham AH, Dilthey AT, Xifara DK et al (2015) Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet 47:1107–1113 · DOI · Paper page
  66. Mycko MP, Cichalewska M, Cwiklinska H, Selmaj KW (2015) miR-155-3p drives the development of autoimmune demyelination by regulation of heat shock protein 40. J Neurosci 35:16504–16515 · DOI · Paper page
  67. Nikic I, Merkler D, Sorbara C, Brinkoetter M, Kreutzfeldt M et al (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17:495–499 · DOI · Paper page
  68. Noorbakhsh F, Ellestad KK, Maingat F, Warren KG, Han MH et al (2011) Impaired neurosteroid synthesis in multiple sclerosis. Brain 134:2703–2721 · DOI
  69. O’Connell RM, Chaudhuri AA, Rao DS, Baltimore D (2009) Inositol phosphatase SHIP1 is a primary target of miR-155. Proc Natl Acad Sci U S A 106:7113–7118 · DOI · Paper page
  70. O’Connell RM, Kahn D, Gibson WS, Round JL, Scholz RL et al (2010) MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33:607–619 · DOI · Paper page
  71. O’Connell RM, Rao DS, Baltimore D (2012) microRNA regulation of inflammatory responses. Annu Rev Immunol 30:295–312 · DOI · Paper page
  72. O’Connell RM, Rao DS, Chaudhuri AA, Baltimore D (2010) Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10:111–122 · DOI · Paper page
  73. O’Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD et al (2008) Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205:585–594 · DOI · Paper page
  74. O’Connell RM, Taganov KD, Boldin MP, Cheng G, Baltimore D (2007) MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104:1604–1609 · DOI · Paper page
  75. O’Neill LA, Sheedy FJ, McCoy CE (2011) MicroRNAs: the fine-tuners of toll-like receptor signalling. Nat Rev Immunol 11:163–175 · DOI
  76. Otaegui D, Baranzini SE, Armananzas R, Calvo B, Munoz-Culla M et al (2009) Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One 4:e6309 · DOI
  77. Paraboschi EM, Solda G, Gemmati D, Orioli E, Zeri G et al (2011) Genetic association and altered gene expression of mir-155 in multiple sclerosis patients. Int J Mol Sci 12:8695–8712 · DOI · Paper page
  78. Payne NL, Sun G, McDonald C, Moussa L, Emerson-Webber A et al (2013) Human adipose-derived mesenchymal stem cells engineered to secrete IL-10 inhibit APC function and limit CNS autoimmunity. Brain Behav Immun 30:103–114 · DOI
  79. Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S et al (2009) Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol 157:48–59 · DOI
  80. Pena-Philippides JC, Caballero-Garrido E, Lordkipanidze T, Roitbak T (2016) In vivo inhibition of miR-155 significantly alters post-stroke inflammatory response. J Neuroinflammation 13:287 · DOI · Paper page
  81. Pender MP, Burrows SR (2014) Epstein-Barr virus and multiple sclerosis: potential opportunities for immunotherapy. Clin Transl Immunol 3:e27 · DOI
  82. Ponomarev ED, Veremeyko T, Weiner HL (2013) MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS. Glia 61:91–103 · DOI · Paper page
  83. Pugliatti M, Rosati G, Carton H, Riise T, Drulovic J et al (2006) The epidemiology of multiple sclerosis in Europe. Eur J Neurol 13:700–722 · DOI · Paper page
  84. Pulkkinen KH, Yla-Herttuala S, Levonen AL (2011) Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. Free Radic Biol Med 51:2124–2131 · DOI
  85. Quinn SR, Mangan NE, Caffrey BE, Gantier MP, Williams BR et al (2014) The role of Ets2 transcription factor in the induction of microRNA-155 (miR-155) by lipopolysaccharide and its targeting by interleukin-10. J Biol Chem 289:4316–4325 · DOI · Paper page
  86. Rahadiani N, Takakuwa T, Tresnasari K, Morii E, Aozasa K (2008) Latent membrane protein-1 of Epstein-Barr virus induces the expression of B-cell integration cluster, a precursor form of microRNA-155, in B lymphoma cell lines. Biochem Biophys Res Commun 377:579–583 · DOI
  87. Ruffell D, Mourkioti F, Gambardella A, Kirstetter P, Lopez RG et al (2009) A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A 106:17475–17480 · DOI · Paper page
  88. Samoilova EB, Horton JL, Chen Y (1998) Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery. Cell Immunol 188:118–124 · DOI
  89. Sanders KA, Benton MC, Lea RA, Maltby VE, Agland S et al (2016) Next-generation sequencing reveals broad down-regulation of microRNAs in secondary progressive multiple sclerosis CD4+ T cells. Clin Epigenetics 8:87 · DOI
  90. Schmidt C (2016) Biology: a degenerative affliction. Nature 540:S2–S3 · DOI
  91. Seddiki N, Brezar V, Ruffin N, Levy Y, Swaminathan S (2014) Role of miR-155 in the regulation of lymphocyte immune function and disease. Immunology 142:32–38 · DOI
  92. Seeger FH, Zeiher AM, Dimmeler S (2013) MicroRNAs in stem cell function and regenerative therapy of the heart. Arterioscler Thromb Vasc Biol 33:1739–1746 · DOI
  93. Singh J, Deshpande M, Suhail H, Rattan R, Giri S (2016) Targeted stage-specific inflammatory microRNA profiling in urine during disease progression in experimental autoimmune encephalomyelitis: markers of disease progression and drug response. J Neuroimmune Pharmacol 11:84–97 · DOI
  94. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D et al (2012) The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8:e1002484 · DOI
  95. So AY, Garcia-Flores Y, Minisandram A, Martin A, Taganov K et al (2012) Regulation of APC development, immune response, and autoimmunity by Bach1/HO-1 pathway in mice. Blood 120:2428–2437 · DOI
  96. Sondergaard HB, Hesse D, Krakauer M, Sorensen PS, Sellebjerg F (2013) Differential microRNA expression in blood in multiple sclerosis. Mult Scler 19:1849–1857 · DOI
  97. Sun HX, Zeng DY, Li RT, Pang RP, Yang H et al (2012) Essential role of microRNA-155 in regulating endothelium-dependent vasorelaxation by targeting endothelial nitric oxide synthase. Hypertension 60:1407–1414 · DOI
  98. Tannahill GM, Iraci N, Gaude E, Frezza C, Pluchino S (2015) Metabolic reprograming of mononuclear phagocytes in progressive multiple sclerosis. Front Immunol 6:106 · DOI
  99. Tarassishin L, Loudig O, Bauman A, Shafit-Zagardo B, Suh HS et al (2011) Interferon regulatory factor 3 inhibits astrocyte inflammatory gene expression through suppression of the proinflammatory miR-155 and miR-155*. Glia 59:1911–1922 · DOI
  100. Teng G, Hakimpour P, Landgraf P, Rice A, Tuschl T et al (2008) MicroRNA-155 is a negative regulator of activation-induced cytidine deaminase. Immunity 28:621–629 · DOI
  101. Thai TH, Calado DP, Casola S, Ansel KM, Xiao C et al (2007) Regulation of the germinal center response by microRNA-155. Science 316:604–608 · DOI
  102. Thome AD, Harms AS, Volpicelli-Daley LA, Standaert DG (2016) microRNA-155 regulates alpha-Synuclein-induced inflammatory responses in models of Parkinson disease. J Neurosci 36:2383–2390 · DOI
  103. Tran EH, Hoekstra K, van Rooijen N, Dijkstra CD, Owens T (1998) Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J Immunol 161:3767–3775 · DOI
  104. Tsitsiou E, Lindsay MA (2009) microRNAs and the immune response. Curr Opin Pharmacol 9:514–520 · DOI
  105. Vaknin I, Kunis G, Miller O, Butovsky O, Bukshpan S et al (2011) Excess circulating alternatively activated myeloid (M2) cells accelerate ALS progression while inhibiting experimental autoimmune encephalomyelitis. PLoS One 6:e26921 · DOI
  106. van den Berg A, Kroesen BJ, Kooistra K, de Jong D, Briggs J et al (2003) High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37:20–28 · DOI
  107. Vicente R, Noel D, Pers YM, Apparailly F, Jorgensen C (2016) Deregulation and therapeutic potential of microRNAs in arthritic diseases. Nat Rev Rheumatol 12:211–220 · DOI
  108. Vigorito E, Kohlhaas S, Lu D, Leyland R (2013) miR-155: an ancient regulator of the immune system. Immunol Rev 253:146–157 · DOI
  109. Vigorito E, Perks KL, Abreu-Goodger C, Bunting S, Xiang Z et al (2007) microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27:847–859 · DOI
  110. Wang J, Wu M, Wen J, Yang K, Li M et al (2014) MicroRNA-155 induction by Mycobacterium Bovis BCG enhances ROS production through targeting SHIP1. Mol Immunol 62:29–36 · DOI
  111. Waschbisch A, Atiya M, Linker RA, Potapov S, Schwab S et al (2011) Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS One 6:e24604 · DOI
  112. Wen Y, Zhang X, Dong L, Zhao J, Zhang C et al (2015) Acetylbritannilactone modulates MicroRNA-155-mediated inflammatory response in ischemic cerebral tissues. Mol Med 21:197–209 · DOI
  113. Wilms H, Sievers J, Rickert U, Rostami-Yazdi M, Mrowietz U et al (2010) Dimethylfumarate inhibits microglial and astrocytic inflammation by suppressing the synthesis of nitric oxide, IL-1beta, TNF-alpha and IL-6 in an in-vitro model of brain inflammation. J Neuroinflammation 7:30 · DOI
  114. Winter J, Jung S, Keller S, Gregory RI, Diederichs S (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228–234 · DOI
  115. Woodbury ME, Freilich RW, Cheng CJ, Asai H, Ikezu S et al (2015) miR-155 is essential for inflammation-induced hippocampal neurogenic dysfunction. J Neurosci 35:9764–9781 · DOI
  116. Wu Q, Wang Q, Mao G, Dowling CA, Lundy SK et al (2017) Dimethyl fumarate selectively reduces memory T cells and shifts the balance between Th1/Th17 and Th2 in multiple sclerosis patients. J Immunol 198:3069–3080 · DOI
  117. Wu XY, Fan WD, Fang R, Wu GF (2014) Regulation of microRNA-155 in endothelial inflammation by targeting nuclear factor (NF)-kappaB P65. J Cell Biochem 115:1928–1936
  118. Yang Y, Ye Y, Su X, He J, Bai W et al (2017) MSCs-derived exosomes and Neuroinflammation, neurogenesis and therapy of traumatic brain injury. Front Cell Neurosci 11:55
  119. Yin Q, McBride J, Fewell C, Lacey M, Wang X et al (2008) MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. J Virol 82:5295–5306 · DOI
  120. Yin Q, Wang X, Roberts C, Flemington EK, Lasky JA (2016) Methylation status and AP1 elements are involved in EBV-mediated miR-155 expression in EBV positive lymphoma cells. Virology 494:158–167 · DOI
  121. Zhang J, Cheng Y, Cui W, Li M, Li B et al (2014) MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 266:56–63 · DOI
  122. Zhang J, Vandevenne P, Hamdi H, Van Puyvelde M, Zucchi A et al (2015) Micro-RNA-155-mediated control of heme oxygenase 1 (HO-1) is required for restoring adaptively tolerant CD4+ T-cell function in rodents. Eur J Immunol 45:829–842 · DOI
  123. Zhang J, Zhang ZG, Lu M, Wang X, Shang X et al (2017) MiR-146a promotes remyelination in a cuprizone model of demyelinating injury. Neuroscience 348:252–263 · DOI · Paper page
  124. Zheng B, Yin WN, Suzuki T, Zhang XH, Zhang Y et al (2017) Exosome-mediated miR-155 transfer from smooth muscle cells to endothelial cells induces endothelial injury and promotes atherosclerosis. Mol Ther 25:1279–1294 · DOI
  125. Zhou H, Huang X, Cui H, Luo X, Tang Y et al (2010) miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 116:5885–5894 · DOI · Paper page
  126. Zhu N, Zhang D, Chen S, Liu X, Lin L et al (2011) Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis 215:286–293 · DOI

Cited by

Sorted by citations

See all 46

Metadata

Authors
McCoy, C. E.
Venue
Advances in Experimental Medicine and Biology
Publisher
Springer Singapore
Published
2017
Pages
111-131
ISSN
  • 0065-2598
  • 2214-8019
DOI
10.1007/978-981-10-5987-2_5
Cited by
46
References
14
Licence
www.springer.com/tdm (unspecified)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review